How many insider declarations has Anderson Woodrow D filed?

Anderson Woodrow D has filed 4 public insider declarations with SEC (Form 4).

What is Anderson Woodrow D's role?

Anderson Woodrow D's reported role is not specified by the regulator across the filings.

Which companies does Anderson Woodrow D report trades for?

Anderson Woodrow D reports trades for 2 companies, including Indivior Pharmaceuticals, Inc..

What is Anderson Woodrow D's declared buy vs sell volume?

Across the available history, declared buys total 93k€ and disposals 0.

← Executives ★ Sign in to follow

AW

Anderson Woodrow D

OFFICERM

·SEC (Form 4)

Indivior Pharmaceuticals, Inc.Indivior Pharmaceuticals, Inc.

0

申报总数

0

公司

€93,105

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Anderson Woodrow D. Officer active across 2 companies, notably Indivior Pharmaceuticals, Inc.. Aggregated, 4 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €93k. Activity tracked since 10 February 2026. The latest transaction was disclosed on 27 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Anderson Woodrow D

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Indivior Pharmaceuticals, Inc. (US)Indivior Pharmaceuticals, Inc. (US)

申报4 总计

▲

Anderson Woodrow D

Chief Accounting Officer高管2026年8月27日Indivior Pharmaceuticals, Inc.

US$53,5350SEC ↗

1,500 股@ US$35.69Common StockSEC:0002014440-26-000012:0

标准退出：2026年11月25日 (T+90)

▲

Anderson Woodrow D

Chief Accounting Officer高管2026年8月5日Indivior Pharmaceuticals, Inc.

US$54,42037SEC ↗

1,500 股@ US$36.280.0013% mcap100.0% 占其流量Common StockSEC:0002014440-26-000010:0

标准退出：2026年11月3日 (T+90)

◇

Anderson Woodrow D

Chief Accounting Officer高管2026年3月3日Indivior Pharmaceuticals, Inc.

0SEC ↗

18,364 股Common StockSEC:0002014440-26-000007:0

◆

Anderson Woodrow D

Chief Accounting Officer高管2026年2月10日Indivior Pharmaceuticals, Inc.

0SEC ↗

6,903 股0Common StockSEC:0002014440-26-000005:0

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

AW

Anderson Woodrow D

OFFICERM

·SEC (Form 4)

Indivior Pharmaceuticals, Inc.Indivior Pharmaceuticals, Inc.

0

申报总数

0

公司

€93,105

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Anderson Woodrow D. Officer active across 2 companies, notably Indivior Pharmaceuticals, Inc.. Aggregated, 4 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €93k. Activity tracked since 10 February 2026. The latest transaction was disclosed on 27 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.